1. Abdel-Dayem, H.M., El-Hilu, S., Sehweil, A., Higazi, B., Jahan, S., Salhat, M., & Al-Mohannadi, S. (1990). Cerebral perfusion changes in schizophrenic patients using Tc-99m Hexamethylpropylene Amineoxime (HMPAO). Clinical Nuclear Medicine, 15, 468–472.
2. Altshuler, L.L., Conrad, A., Kovelman, J.A., & Scheibel, A. (1987). Hippo- campal pyramidal cell orientation in schizophrenia. Archives of General Psychiatry, 44, 1094–1098.
3. Andreasen, N.C., Ehrardt, J.C., Swayze, V.W., Alliger, R.J., Yuh, W.T.C., Cohen, G., & Zeibell, S. (1990). Magnetic resonance imaging of the brain in schizophrenia. Archives of General Psychiatry, 47, 35–44.
4. Andreasen, N.C., & Olsen, S. (1982). Negative versus positive schizophrenia. Archives of General Psychology, 39, 789–794.
5. Anzai, N., Okazaki, Y., Miyauchi, M., Harada, S.I., Kanou, Y., Sasaki, T., Kumagai, N., Shikiba, N., Iwanami, A., Iadi, S., Hiramatsu, K.I., Niwa, S.I., & Ohta, M. (1988). Early neuroleptic medication within one year after onset can reduce risk of later relapses in schizophrenic patients. Annual Report Pharmacopsychiatric Research Foundation, 19, 258–265.